Cellectis
CLLS
$2.56
Share price
1.59%
Change (1 day)
31.28%
Change (1 year)
Categories
Cellectis (CLLS) Fails to deliver data
Key failure to deliver metrics for Cellectis:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.02 M
- Last 3 months FTD volume: $0.21 M
- Last year FTD volume: $2.71 M
Failures to deliver for Cellectis (CLLS) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Cellectis (CLLS) - since 2015
Volume in USD (price x number of shares), data since 2015Cellectis (CLLS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.31 M | -87.76% |
| 2023 | $2.53 M | -35.43% |
| 2022 | $3.92 M | -74.81% |
| 2021 | $15.59 M | -26.71% |
| 2020 | $21.27 M | 2750.05% |
| 2019 | $0.74 M | -93.48% |
| 2018 | $11.44 M | 85.32% |
| 2017 | $6.17 M | -25.24% |
| 2016 | $8.26 M | -76.95% |
| 2015 | $35.83 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $0.97 M | $0.14 B | 🇺🇸 USA |
 uniQure QURE | $0.9 M | $3.62 M | 🇳🇱 Netherlands |
 Novavax NVAX | $37.88 M | $0.32 B | 🇺🇸 USA |